Tm Bioscience secures multi-year extension to Luminex partnership:
This article was originally published in Clinica
Executive Summary
Canada's Tm Bioscience and Austin, Texas-based Luminex have extended an existing licensing agreement, which gives the former company rights to sell DNA-based molecular tests used on Luminex' xMAP instrument. The renewed multi-year contract will also give Tm Bioscience distribution rights to Luminex's new LX200 system. Tm Bioscience, which develops genetic tests based on its Tag-It universal array technology, and Luminex, which specialises in bead-based bioassay multiplexing, formed their partnership in 2001.